Ocrelizumab is one of three B-cell therapies approved by the FDA to treat MS. This medicine sticks to B cells and keeps them from causing damage. It has the approval to treat: Clinically isolated ...
B cells are a type of white blood cell. They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have MS, ...
B cells and antibodies account for the most prominent immunodiagnostic feature in patients with multiple sclerosis (MS), namely oligoclonal bands. Furthermore, evidence is accumulating that B cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results